Cargando…

Blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats

BACKGROUND: Knowing the variability of blood coagulation responses to liver damage of different origins can provide a key to curing liver tissues or to mitigating treatment side effects. The aim of the present work was to compare the changes in the main components of hemostasis under experimental dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Korolova, Daria, Gryshchenko, Viktoriya, Chernyshenko, Tamara, Platonov, Oleh, Hornytska, Olha, Chernyshenko, Volodymyr, Klymenko, Pavlo, Reshetnik, Yevdokiia, Platonova, Tetyana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986226/
https://www.ncbi.nlm.nih.gov/pubmed/36574273
http://dx.doi.org/10.1002/ame2.12301
_version_ 1784901116788473856
author Korolova, Daria
Gryshchenko, Viktoriya
Chernyshenko, Tamara
Platonov, Oleh
Hornytska, Olha
Chernyshenko, Volodymyr
Klymenko, Pavlo
Reshetnik, Yevdokiia
Platonova, Tetyana
author_facet Korolova, Daria
Gryshchenko, Viktoriya
Chernyshenko, Tamara
Platonov, Oleh
Hornytska, Olha
Chernyshenko, Volodymyr
Klymenko, Pavlo
Reshetnik, Yevdokiia
Platonova, Tetyana
author_sort Korolova, Daria
collection PubMed
description BACKGROUND: Knowing the variability of blood coagulation responses to liver damage of different origins can provide a key to curing liver tissues or to mitigating treatment side effects. The aim of the present work was to compare the changes in the main components of hemostasis under experimental drug‐induced hepatosis and hepatitis in rats. METHODS: We modeled diclofenac‐induced hepatitis and tetracycline‐induced hepatosis. Hemostasis response was gauged by measuring fibrinogen, factor X, protein C (PC), and prothrombin in plasma. The decarboxylated form of prothrombin was detected by measuring prothrombin index and ecamulin index. Platelet reactivity was studied using aggregometry. RESULTS: Both hepatitis and hepatosis decreased the synthesis of fibrinogen, factor X, and prothrombin. However, protein carboxylation was not disrupted in hepatosis but was much impaired in hepatitis. PC decreased in both models as a consequence of its consumption possibly during inflammatory response. Platelet aggregation rate was lower in hepatosis but higher in hepatitis. CONCLUSIONS: Our findings imply the need for a thorough monitoring of the hemostasis system in liver diseases to avoid possible thrombotic complications. Its state indicates the disorder's rate and character.
format Online
Article
Text
id pubmed-9986226
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99862262023-03-07 Blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats Korolova, Daria Gryshchenko, Viktoriya Chernyshenko, Tamara Platonov, Oleh Hornytska, Olha Chernyshenko, Volodymyr Klymenko, Pavlo Reshetnik, Yevdokiia Platonova, Tetyana Animal Model Exp Med Regular Articles BACKGROUND: Knowing the variability of blood coagulation responses to liver damage of different origins can provide a key to curing liver tissues or to mitigating treatment side effects. The aim of the present work was to compare the changes in the main components of hemostasis under experimental drug‐induced hepatosis and hepatitis in rats. METHODS: We modeled diclofenac‐induced hepatitis and tetracycline‐induced hepatosis. Hemostasis response was gauged by measuring fibrinogen, factor X, protein C (PC), and prothrombin in plasma. The decarboxylated form of prothrombin was detected by measuring prothrombin index and ecamulin index. Platelet reactivity was studied using aggregometry. RESULTS: Both hepatitis and hepatosis decreased the synthesis of fibrinogen, factor X, and prothrombin. However, protein carboxylation was not disrupted in hepatosis but was much impaired in hepatitis. PC decreased in both models as a consequence of its consumption possibly during inflammatory response. Platelet aggregation rate was lower in hepatosis but higher in hepatitis. CONCLUSIONS: Our findings imply the need for a thorough monitoring of the hemostasis system in liver diseases to avoid possible thrombotic complications. Its state indicates the disorder's rate and character. John Wiley and Sons Inc. 2022-12-27 /pmc/articles/PMC9986226/ /pubmed/36574273 http://dx.doi.org/10.1002/ame2.12301 Text en © 2022 The Authors. Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Regular Articles
Korolova, Daria
Gryshchenko, Viktoriya
Chernyshenko, Tamara
Platonov, Oleh
Hornytska, Olha
Chernyshenko, Volodymyr
Klymenko, Pavlo
Reshetnik, Yevdokiia
Platonova, Tetyana
Blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats
title Blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats
title_full Blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats
title_fullStr Blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats
title_full_unstemmed Blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats
title_short Blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats
title_sort blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats
topic Regular Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986226/
https://www.ncbi.nlm.nih.gov/pubmed/36574273
http://dx.doi.org/10.1002/ame2.12301
work_keys_str_mv AT korolovadaria bloodcoagulationfactorsandplateletresponsetodruginducedhepatitisandhepatosisinrats
AT gryshchenkoviktoriya bloodcoagulationfactorsandplateletresponsetodruginducedhepatitisandhepatosisinrats
AT chernyshenkotamara bloodcoagulationfactorsandplateletresponsetodruginducedhepatitisandhepatosisinrats
AT platonovoleh bloodcoagulationfactorsandplateletresponsetodruginducedhepatitisandhepatosisinrats
AT hornytskaolha bloodcoagulationfactorsandplateletresponsetodruginducedhepatitisandhepatosisinrats
AT chernyshenkovolodymyr bloodcoagulationfactorsandplateletresponsetodruginducedhepatitisandhepatosisinrats
AT klymenkopavlo bloodcoagulationfactorsandplateletresponsetodruginducedhepatitisandhepatosisinrats
AT reshetnikyevdokiia bloodcoagulationfactorsandplateletresponsetodruginducedhepatitisandhepatosisinrats
AT platonovatetyana bloodcoagulationfactorsandplateletresponsetodruginducedhepatitisandhepatosisinrats